Abstract: The present invention relates to a method for determining both (a) the haematocrit value and (b) the fibrinogen content in whole blood of an individual in less than 5 minutes, as well as to associated portable apparatus.
Type:
Grant
Filed:
October 15, 2014
Date of Patent:
March 6, 2018
Assignees:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICAL, ETAT FRANCAIS (MINISTERE DE LA DEFENSE), SERVICE DE SANTE DES ARMEES, ASSITANCE PUBLIQUE—HOPITAUX DE PARIS, UNIVERSITE PARIS DECARTES
Inventors:
Pascale Gaussem, Anne Godier, Isabelle Gouin-Thibault, Bernard Le Bonniec, Anne-Celine Martin, Nyoucha Morravedge, Marc Samama
Abstract: The present invention relates to a culture support for cultivating hematopoietic stem cells (HSCs) and/or hematopoietic progenitors (HPs), comprising a calcium biomaterial, osteoclasts, endothelial cells and mesenchymatous stem cells (MSCs) and/or osteoblasts and/or adipocytes. The present invention also relates to a method for preparing such a culture support, and an in vitro HSC and/or HP cultivation method. The use of such a culture support for studying cellular mechanisms involved in hematopoiesis and/or differentiation of HSC/HPs and/or for studying the efficacy and/or the toxicity of a medicament candidate is also described.
Type:
Grant
Filed:
August 14, 2012
Date of Patent:
September 5, 2017
Assignees:
ETAT FRANCAIS (MINISTERE DE LA DEFENSE), SERVICE DE SANTE DES ARMEES, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Inventors:
Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdiles
Abstract: The present invention relates to a culture support for cultivating hematopoietic stem cells (HSCs) and/or hematopoietic progenitors (HPs), comprising a calcium biomaterial, osteoclasts, endothelial cells and mesenchymatous stem cells (MSCs) and/or osteoblasts and/or adipocytes. The present invention also relates to a method for preparing such a culture support, and an in vitro HSC and/or HP cultivation method. The use of such a culture support for studying cellular mechanisms involved in hematopoiesis and/or differentiation of HSC/HPs and/or for studying the efficacy and/or the toxicity of a medicament candidate is also described.
Type:
Application
Filed:
August 14, 2012
Publication date:
November 27, 2014
Applicants:
Institut Nationalde la Sante et de la Recherche Medicale (INSERM), ETAT FRANCAIS (MINISTERE DE LA DEFENSE), SERVICE DE SANTE DES ARMEES
Inventors:
Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdiles
Abstract: A method of preparing a germinalized hypervariable antibody region directed against a target, as well as the antibodies, antibody fragments, vectors and compositions including the germinalized hypervariable region.
Type:
Application
Filed:
September 21, 2010
Publication date:
July 18, 2013
Applicant:
ETAT FRANÇAIS (MINISTÈRE DE LA DÉFENSE), SERVICE DE SANTÉ DES ARMÉES
Abstract: The present invention relates to a lyophilized plasma, resulting from a mixture of plasmas originating from selected donors, which is virally attenuated and compatible with all blood groups and to the process for obtaining same.
Type:
Application
Filed:
August 16, 2011
Publication date:
June 6, 2013
Applicant:
ETAT FRANCAIS (MINISTERE DE LA DEFENSE), SERVICE DE SANTE DES ARMEES